atugen Accelerates Successful Drug Discovery Programme at ALTANA and Receives Two Milestone Payments
December 04, 2002 04:00 ET | atugen AG
BERLIN, Germany, Dec. 4, 2002 (PRIMEZONE) -- atugen AG today announced that it has received two milestone payments from ALTANA Pharma AG, the international Pharmaceuticals Group of ALTANA AG...
atugen Announces New Collaboration with Schering AG, Germany
September 17, 2002 02:14 ET | atugen AG
BERLIN, Germany, Sept. 17, 2002 (PRIMEZONE) -- atugen AG today announced a new collaboration with Schering AG (Frankfurt:SCHG) (NYSE:SHR) to validate a number of novel drug targets associated with...
atugen Announces Functional Genomics Collaboration with Byk Gulden
May 14, 2002 02:44 ET | atugen AG
BERLIN, Germany, May 14, 2002 (PRIMEZONE) -- atugen AG today announced a three year, collaboration with Byk Gulden, the pharmaceutical group of ALTANA AG, to validate a number of novel genetic...
atugen AG Signs Technology Evaluation Agreement with Kinetek Pharmaceuticals
February 20, 2002 06:29 ET | atugen AG
BERLIN, Germany, Feb. 20, 2002 (PRIMEZONE) -- atugen AG announced today the signing of a technology evaluation agreement with Kinetek Pharmaceuticals, Inc., Vancouver, Canada, a biopharmaceutical...
atugen AG Signs Target Validation Agreement with UCSF
January 23, 2002 03:50 ET | atugen AG
BERLIN, Germany, Jan. 23, 2002 (PRIMEZONE) -- atugen AG, today announced the signing of an agreement with the University of California, San Francisco to utilize atugen's technology to validate the...
atugen AG Announces Target Validation Collaboration with Oxford GlycoSciences
December 11, 2001 05:31 ET | atugen AG
BERLIN, Germany, Dec. 11, 2001 (PRIMEZONE) -- atugen AG announced today that it has signed a collaboration with Oxford GlycoSciences (LSE:OGS) (Nasdaq:OGSI) to validate high priority...
atugen AG Signs Evaluation Agreement with Byk Gulden (with link)
November 19, 2001 02:20 ET | atugen AG
BERLIN, Germany, Nov. 19, 2001 (PRIMEZONE) -- atugen AG announced today that it has signed an evaluation agreement with the pharmaceuticals group of ALTANA, Byk Gulden (Constance), to investigate the...